How A Cloud ELN Empowers Collaboration

By Matt McGowan, Field Application Scientist

The pressure to increase pharmaceutical R&D productivity is widely felt in the industry. Market forces, government regulations and targeted therapies for smaller patient populations are dictating that more high-quality therapeutic candidates are promoted to the clinic cheaply and quickly. This combination of “more/better/faster/cheaper” is predictably challenging. Innovative companies are deploying processes and tools in drug discovery and early development that are designed to increase the rate of their scientific progress.

Much of the valuable information needed to drive R&D productivity exists in lab notebooks – paper notebooks or Electronic Lab Notebooks (ELN). Information in paper notebooks is difficult to access by its very nature. Previous generations of ELNs suffer from a tendency to be placed inside existing siloes. Different teams use different ELN systems, have technical barriers between geographies, or ELNs are unable to be shared between external partners due to IP concerns. PerkinElmer’s Signals™ Notebook takes a modern approach to storing, sharing and reporting experimental information which removes the barriers that cause silos while still maintaining strict data security.